KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.Company Information
- Company Name
- KESTRA MEDICAL TECHNOLOGIES, LTD.
- CIK
- CIK0001877184
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- KMTS: Nasdaq
- Fiscal Year End
- April 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- KMTS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-26
- Last sale
- 2026-09-21
- Shares purchased (TTM)
- 10,000
- Shares sold (TTM)
- 302,364
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 53,851,426
- Shares outstanding
- 58,566,467
- Ownership
- 91.95%
Earnings Market Reaction
- Filing date
- 2026-09-14
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West Affum Intermediate Holdings Corp | - | - | - | - | - | 0 | - | ||||||
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 69 | 100 | 291 | 175 | 201 | 238 | 54 | ||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | - | - | - | - | - | - | -0 | ||||||
| Short Term Investments | - | 97 | - | - | - | - | - | ||||||
| Receivables Net Current | 15 | 15 | 13 | 10 | 9 | 8 | - | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 3 | 3 | 3 | 3 | - | ||||||
| Assets Current | 226 | 222 | 314 | 195 | 221 | 255 | - | ||||||
| Long Term Investments | - | 66 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 2 | 2 | 2 | 2 | - | ||||||
| Deposits Assets Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | - | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Property Plant And Equipment Net | 64 | 59 | 54 | 46 | 40 | 35 | - | ||||||
| Other Assets Noncurrent | 6 | 6 | 6 | 1 | 1 | 1 | - | ||||||
| Assets | 347 | 358 | 379 | 247 | 266 | 296 | - | ||||||
Liabilities Current | |||||||||||||
| Accounts Payable Current | 26 | 27 | 24 | 20 | 19 | 24 | - | ||||||
| Accrued Liabilities Current | 22 | 23 | 19 | 15 | 14 | 14 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities Current | 48 | 50 | 43 | 36 | 32 | 38 | - | ||||||
| Operating Lease Liability Noncurrent | 4 | 4 | 4 | 3 | 3 | 3 | - | ||||||
| Warrants And Rights Outstanding | - | 1 | 2 | 2 | 5 | 8 | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Long Term Debt Noncurrent | 72 | 43 | 42 | 42 | 41 | 41 | - | ||||||
| Liabilities | 125 | 99 | 91 | 83 | 82 | 90 | - | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | |||||||||||||
| Common Stock Value | 59 | 58 | 58 | 51 | 51 | 51 | 0 | ||||||
| Additional Paid In Capital Common Stock | 860 | 853 | 843 | 691 | 679 | 674 | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | -0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -696 | -652 | -613 | -579 | -546 | -520 | - | ||||||
| Stockholders Equity | 222 | 260 | 288 | 164 | 184 | 205 | -258 | ||||||
| Liabilities And Stockholders Equity | 347 | 358 | 379 | 247 | 266 | 296 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | 0 | - | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 59 | 58 | 58 | 51 | 51 | 51 | 100 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | 0 | - | ||||||
| Shares Outstanding | 59 | 58 | 58 | 51 | 51 | 51 | 100 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialKESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) — SEC Financial Statements & Analysis
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is a surgical & medical instruments & apparatus company, incorporated in D0. KESTRA MEDICAL TECHNOLOGIES, LTD. trades on Nasdaq as: KMTS. KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14. Based on that filing, KESTRA MEDICAL TECHNOLOGIES, LTD. carries a market cap of $1.34B, a P/E ratio of -8.92x, a P/B ratio of 6.01x, a P/S ratio of 12.53x, an enterprise value of $1.34B, and an EV/EBITDA multiple of -9.99x. On profitability, it posts a gross margin of 53.89%, an operating margin of -134.48%, a net margin of -140.43%, a Return on Equity (ROE) of -73.74%, a Return on Assets (ROA) of -48.85%, and a Return on Invested Capital (ROIC) of -113.82%. Per share, it reports EPS of $-2.56, diluted EPS of $-2.56, free cash flow per share of $-2.10, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 4.69x, a quick ratio of 4.59x, working capital of $178.00M, a debt-to-equity ratio of 0.56x, a debt ratio of 0.36, an interest coverage ratio of -18.98x, free cash flow of $-122.78M (TTM), and net debt of $3.60M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.34B
- P/E TTM
- -8.92x
- EPS TTM
- $-2.56
- P/B TTM
- 6.01x
- ROE TTM
- -73.74%
- ROA TTM
- -48.85%
- Debt To Equity
- 0.56x
- Free Cash Flow TTM
- $-122.78M
Data as of 2026-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is KESTRA MEDICAL TECHNOLOGIES, LTD. in?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does KMTS trade on?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) trades on the Nasdaq.
Where is KESTRA MEDICAL TECHNOLOGIES, LTD. incorporated?
KESTRA MEDICAL TECHNOLOGIES, LTD. is incorporated in Bermuda.
When was KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s most recent SEC filing?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14.
What is KMTS's market cap?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) has a market capitalization of $1.34B as of 2026-07-31.
What is KMTS's EPS (earnings per share)?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s trailing twelve month EPS is $-2.56 as of 2026-07-31.
What is KMTS's ROE (return on equity)?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s trailing twelve month Return on Equity (ROE) is -73.74% as of 2026-07-31.
What is KMTS's ROA (return on assets)?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s trailing twelve month Return on Assets (ROA) is -48.85% as of 2026-07-31.
What is KMTS's ROIC (return on invested capital)?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s trailing twelve month Return on Invested Capital (ROIC) is -113.82% as of 2026-07-31.
What is KMTS's EV/EBITDA?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)'s trailing twelve month EV/EBITDA is -9.99x as of 2026-07-31.